Telik

Quick facts

Phase 3 pipeline

• TLK286 HCl for injection · Oncology
  TLK286 HCl for injection is a proteasome inhibitor.
• TLK286 in Combination with Carboplatin · Oncology
  TLK286 is a histone deacetylase inhibitor that works by blocking the activity of histone deacetylases, leading to the inhibition of cancer cell growth and induction of apoptosis.

Phase 2 pipeline

• Canfosfamide HCl for injection
• TLK286

Phase 1 pipeline

• Ezatiostat Hydrochlorine
• TLK199 HCl Liposomes for Injection
• TLK286, cisplatin
• TLK286 in combination with docetaxel

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Telik portfolio CI brief
• Telik pipeline updates RSS